Skip to content

Transit Infusion Catheter

by Cordis Neurovascular, Inc.

510(k) K952874

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK952874 Date21 Aug 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KRA
Device Class
Class II
Regulation
21 CFR Part 870.1210
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Transit Infusion Catheter is a catheter, continuous flush designed for vascular access and infusion therapy. It facilitates the delivery of fluids, medications, or contrast agents directly into the bloodstream while maintaining patency through continuous flushing.

This device is intended for single-use in neurovascular and cardiovascular settings, as evidenced by its FDA 510(k) clearance under product code KRA and regulation 870.1210. Supplied sterile, it is classified as Class II and requires no additional sterilization before use. Multiple sizes and configurations are available, as indicated by the associated FEI numbers.

Other devices from Cordis Neurovascular, Inc.

See all devices from Cordis Neurovascular, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical settings is the Transit Infusion Catheter designed for, and how does it differ from standard catheters in those areas?

    The Transit Infusion Catheter is specifically designed for neurovascular and cardiovascular settings, where continuous infusion and flushing are critical. Unlike standard catheters, it is engineered to deliver fluids, medications, or contrast agents *directly into the bloodstream* while maintaining vascular access through continuous flushing. This dual function—infusion *and* patency maintenance—distinguishes it for procedures requiring precise, uninterrupted delivery, such as thrombolysis or diagnostic imaging in high-risk vascular areas.

  • Is the Transit Infusion Catheter reusable, or is it intended for single-use only? What does this mean for my workflow?

    The Transit Infusion Catheter is intended for single-use only, as explicitly stated in its FDA 510(k) clearance. This means each catheter is sterile upon packaging and should not be reused or reprocessed. For your workflow, this simplifies infection control by eliminating the need for sterilization between patients, but you’ll need to account for inventory turnover and proper disposal protocols to ensure availability during procedures.

  • How do I know which size or configuration of Transit Infusion Catheter to order, and are there multiple options available?

    The Transit Infusion Catheter comes in multiple sizes and configurations, as evidenced by the extensive list of FEI numbers (e.g., 3012543881, 3003495548, etc.) in the regulatory records. These variations likely correspond to differences in length, diameter, or tip design to accommodate diverse anatomical needs (e.g., cerebral arteries vs. peripheral vasculature). Consult your manufacturer’s product catalog or a representative to match the catheter’s specifications to your patient’s vascular anatomy and procedural requirements.

  • Does the Transit Infusion Catheter require additional sterilization before use, or is it already sterile when received?

    The Transit Infusion Catheter is supplied sterile and does not require additional sterilization before use. This is confirmed by the manufacturer’s description and the device’s classification as sterile upon packaging. Always verify the sterility indicator (e.g., peel seal) is intact prior to opening to ensure sterility is maintained.

  • What regulatory pathway was followed for the Transit Infusion Catheter’s clearance, and how does this affect its use in clinical practice?

    The Transit Infusion Catheter received FDA 510(k) clearance under product code KRA and regulation 870.1210, with a decision of *Substantially Equivalent* (SESE) to a predicate device. This traditional clearance pathway ensures the device meets safety and effectiveness standards for its intended use in neurovascular and cardiovascular applications. Clinically, this means the catheter is legally marketable in the U.S. for its described purposes, but always adhere to facility-specific protocols and manufacturer instructions for proper handling and use.